Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence

References

• DegenhardtLBucelloCCalabriaBWhat data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviewsDrug Alcohol Depend20111178510121377813
   PubMed Web of Science ®Google Scholar
• FischerBArgentoEPrescription opioid related misuse, harms, diversion and interventions in Canada: a reviewPain Physician20125ES191ES20322786457
   PubMed Web of Science ®Google Scholar
• FriedlandGInfectious disease comorbidities adversely affecting substance users with HIV: hepatitis C and tuberculosisJ Acquir Immune Defic Syndr201055S37S4221045598
   PubMed Web of Science ®Google Scholar
• StockmanJKStrathdeeSAHIV among people who use drugs: a global perspective of populations at riskJ Acquir Immune Defic Syndr201055S17S2221045594
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA)State Estimates of Substance Use and Mental Disorders from the 2008–2009 National Surveys on Drug Use and HealthRockville, MDSAMHSA2011
   Google Scholar
• United Nations Office on Drugs and Crime (UNODC)World Drug Report 2013ViennaUN2013 Available from: http://www.unodc.org/unodc/secured/wdr/wdr2013/World_Drug_Report_2013.pdfAccessed November 18, 2013
   Google Scholar
• European Monitoring Center on Drugs and Drug Abuse (EMCDDA)Annual Report 2011: The State of the Drugs Problem in EuropeLuxembourgEMCDDA2011 Available from: http://www.emcdda.europa.eu/publications/annual-report/2011Accessed November 18, 2013
   Google Scholar
• HolmesDPrescription drug addiction: the treatment challengeLancet2012379171822232799
   PubMed Web of Science ®Google Scholar
• Royal Australasian College of Physicians (RACP)Prescription Opioid Policy: Improving Management of Chronic Nonmalignant Pain and Prevention of Problems Associated with Prescription Opioid UseSydneyRACP2009 Available from: https://www.racp.edu.au/index.cfm?objectid=EA87198D-CA47-AB21-072D9B2F26FD4AA3Accessed November 18, 2013
   Google Scholar
• SigmonSCharacterizing the emerging population of prescription opioid abusersAm J Addict20061520821216923666
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services AdministrationDrug Abuse Warning Network, 2011: national estimates of drug-related emergency department visits2013 Available from: http://www.Samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htmAccessed November 18, 2013
   Google Scholar
• Gwin MitchellSKellySMBrownBSUses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, MarylandAm J Addict20091834635519874152
   PubMed Web of Science ®Google Scholar
• SohlerNLLiXKuninsHVHome- versus office-based buprenorphine induction for opioid-dependent patientsJ Subst Abuse Treat20103815315919801178
   PubMed Web of Science ®Google Scholar
• AmatoLMinozziSDavoliMVecchiSPsychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxificationCochrane Database Syst Rev20119CD00503121901695
   PubMed Web of Science ®Google Scholar
• FriedmanSRTempalskiBCooperHEstimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug usersJ Urban Health20048137740015273263
   PubMed Web of Science ®Google Scholar
• PetersonJASchwartzRPMitchellSGWhy don’t out-of-treatment individuals enter methadone treatment programs?Int J Drug Policy201021364218805686
   PubMed Web of Science ®Google Scholar
• PopovaSRehmJFischerBAn overview of illegal opioid use and health services utilization in CanadaPublic Health200612032032816476455
   PubMed Web of Science ®Google Scholar
• AuriacombeMFatseasMDubernetJDaulouedeJPTignolJFrench field experience with buprenorphineAm J Addict200413S17S2815204673
   PubMed Web of Science ®Google Scholar
• FatseasMAuriacombeMWhy buprenorphine is so successful in treating opiate addiction in FranceCurr Psychiatry Rep2007935836417915074
   PubMedGoogle Scholar
• MooreBFiellinDABarryDTPrimary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patientsJ Gen Intern Med20072252753017372805
   PubMed Web of Science ®Google Scholar
• FiellinDAThe first three years of buprenorphine in the United States: experience to date and future directionsJ Addict Med20071626721768936
   PubMed Web of Science ®Google Scholar
• KnudsenHJAbrahamAJJohnsonJARomanPMBuprenorphine adoption in the National Drug Abuse Treatment Clinical Trials NetworkJ Subst Abuse Treat20093730731219577406
   PubMed Web of Science ®Google Scholar
• ParranTVAdelmanCAMerkinBLong-term outcomes of office-based buprenorphine/naloxone maintenance therapyDrug Alcohol Depend2010106566019717249
   PubMed Web of Science ®Google Scholar
• BellJTrinhLButlerBRandallDRubinGComparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatmentAddiction20091041193120019563562
   PubMed Web of Science ®Google Scholar
• JonesESMooreBASindelarJLO’ConnorPGSchottenfeldRSFiellinDACost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patientsDrug Alcohol Depend20099913214018804923
   PubMed Web of Science ®Google Scholar
• NielsenSDietzePCantwellKLeeNTaylorDMethadone and buprenorphine related ambulance attendances: a population-based indicator of adverse eventsJ Subst Abuse Treat20083545746118295435
   PubMed Web of Science ®Google Scholar
• SmithMYBaileyJEWoodyGEKleberHDAbuse of buprenorphine in the United States: 2003–2005Journal of Addictive Diseases20072610711118018814
   PubMed Web of Science ®Google Scholar
• ViraniASBezchlibnyk-ButlerKZJeffriesJJProcyshynRMClinical Handbook of Psychotropic Drugs19th edBernHogrefe and Huber2012
   Google Scholar
• MelloNKMendelsonJBehavioral pharmacology of buprenorphineDrug Alcohol Depend1985142833033888577
   PubMed Web of Science ®Google Scholar
• LutfyKCowanABuprenorphine: a unique drug with complex pharmacologyCurr Neuropharmacol2004239540218997874
   PubMedGoogle Scholar
• WalshSPrestonKStitzerMConeEBigelowGClinical pharmacology of buprenorphine: ceiling effects at high dosesClin Pharmacol Ther1994555695808181201
   PubMed Web of Science ®Google Scholar
• StrainECPrestonKLiebsonIBigelowGBuprenorphine effects in methadone-maintained volunteers: effect at two hours after methadoneJ Pharmacol Exp Ther19952726286387853176
   PubMed Web of Science ®Google Scholar
• Centre for Addiction and Mental HealthBuprenorphine/Naloxone for Opioid Dependence: Clinical Practice GuidelineTorontoCAMH2012 Available from: http://knowledgex.camh.net/primary_care/guidelines_materials/Documents/buprenorphine_naloxone_gdlns2012.pdfAccessed November 18, 2013
   Google Scholar
• Substance Abuse and Mental Health Services AdministrationClinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction: A Treatment Improvement Protocol (TIP) 40Rockville, MDSAMHSA2004 Available from: http://buprenorphine.samhsa.gov/Bup_Guidelines.pdfAccessed November 18, 2013
   Google Scholar
• WessonDRBuprenorphine in the treatment of opiate dependence: its pharmacology and social context of use in the USJ Psychoactive Drugs2004Suppl 211912815279124
   PubMed Web of Science ®Google Scholar
• AmassLLingWFreeseTEBringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA clinical trials network field experienceAm J Addict200413Suppl 1S42S6615204675
   PubMed Web of Science ®Google Scholar
• CaldieroRParranTAdelmanCPicheBInpatient initiation of buprenorphine maintenance vs detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?Am J Addict2006151716449087
   PubMed Web of Science ®Google Scholar
• WhiteJBellJSaundersJOpen-label dose-finding trial of buprenorphine implants (Probuphine) for treatment of heroin dependenceDrug Alcohol Depend2009103374319403243
   PubMed Web of Science ®Google Scholar
• SchuhKWalshSStitzerMOnset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humansPsychopharmacology199914516217410463317
   PubMed Web of Science ®Google Scholar
• LingWJacobsPHillhouseMFrom research to the real world: buprenorphine in the decade of the Clinical Trials NetworkJ Subst Abuse Treat201038Suppl 1S53S6020307796
   PubMed Web of Science ®Google Scholar
• ChiangCNHawksRLPharmacokinetics of the combination tablet of buprenorphine and naloxoneDrug Alcohol Depend200370Suppl 2S39S4712738349
   PubMed Web of Science ®Google Scholar
• BigelowGEPrestonKLiebsonIAbuse liability assessment of buprenorphine-naloxone combinationsNIDA Res Monogr1987761451492449616
   PubMedGoogle Scholar
• PrestonKLBigelowGLiebsonIBuprenorphine and naloxone alone and in combination in opioid-dependent humansPsychopharmacology1988944844902453895
   PubMed Web of Science ®Google Scholar
• US Food and Drug AdministrationDrugs@FDA: FDA-approved drug products Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfmAccessed November 18, 2013
   Google Scholar
• Community Care Behavioral Health OrganizationSupporting recovery from opioid addiction: community care best practice guidelines for buprenorphine and Suboxone2013 Available from: http://www.ct.gov/dmhas/lib/dmhas/publications/Community_Care_BP_Guidelines_for_Buprenorphine_and_Suboxone.pdfAccessed November 18, 2013
   Google Scholar
• BroersBGinerFDumontPMinoAInpatient opiate detoxification in Geneva: follow-up at 1 and 6 monthsDrug Alcohol Depend200058859210669058
   PubMed Web of Science ®Google Scholar
• GossopMClonidine and the treatment of the opiate withdrawal syndromeDrug Alcohol Depend1988212532593048954
   PubMed Web of Science ®Google Scholar
• VaillantGEWhat can long-term follow-up teach us about relapse and prevention of relapse in addiction?Br J Addict198883114711573191263
   PubMedGoogle Scholar
• CornishRMacleodJStrangJVickermanPHickmanMRisk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research DatabaseBMJ2010341c547520978062
   PubMed Web of Science ®Google Scholar
• KimberJCopelandLHickmanMSurvival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatmentBMJ2010341c317220595255
   PubMed Web of Science ®Google Scholar
• DoleVPNyswanderMEHeroin addiction – a metabolic diseaseArch Intern Med196712019246028693
   PubMed Web of Science ®Google Scholar
• JohnsonREStrainECAmassLBuprenorphine: how to use it rightDrug Alcohol Depend200370S59S7712738351
   PubMed Web of Science ®Google Scholar
• FiellinDKleberHTrumble-HejdukJMcLellanAKostenTConsensus statement on office-based treatment of opioid dependence using buprenorphineJ Subst Abuse Treat20042715315915450648
   PubMed Web of Science ®Google Scholar
• Schering-Plough CanadaSuboxone Product MonographKirkland, QCSchering-Plough Canada2007
   Google Scholar
• KostenTRO’ConnorPGManagement of drug and alcohol withdrawalN Engl J Med20033481786179512724485
   PubMed Web of Science ®Google Scholar
• DijkstraBAKrabbePFDe JongCAvan der StaakCPPrediction of withdrawal symptoms during opioid detoxificationJ Opioid Manag2008431131919070269
   PubMedGoogle Scholar
• FarrellMOpiate withdrawalAddiction199489147114757841858
   PubMed Web of Science ®Google Scholar
• KleberHDetoxification from narcoticsLowinsonJHRuizPSubstance AbuseBaltimoreWilliams & Wilkins1981
   Google Scholar
• TompkinsDABigelowGEHarrisonJAJohnsonREFudalaPJStrainECConcurrent validation of the Clinical Opiate Withdrawal Scale (COWS) and single-item indices against the Clinical Institute Narcotic Assessment (CINA) opioid withdrawal instrumentsDrug Alcohol Depend200910515415919647958
   PubMed Web of Science ®Google Scholar
• GundersonEWLevinFRRomboneMMVosburgSKKleberHDImproving temporal efficiency of outpatient buprenorphine inductionAm J Addict20112039740421838837
   PubMed Web of Science ®Google Scholar
• DucharmeSFraserRGillKUpdate on the clinical use of buprenorphine in opioid-related disordersCan Family Physician2012583741
   PubMed Web of Science ®Google Scholar
• MattickRKimberJDavoliMBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceCochrane Database Syst Rev20082CD00220718425880
   PubMed Web of Science ®Google Scholar
• NielsenSHillhouseMThomasCHassonALingWA comparison of buprenorphine taper outcomes between prescription opioid and heroin usersJ Addict Med20137333823222095
   PubMed Web of Science ®Google Scholar
• SoykaMZinggCKollerGKuefnerHRetention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized studyInt J Neuropsychopharmacol20081164165318205978
   PubMed Web of Science ®Google Scholar
• WhitleySDSohlerNLKuninsHVFactors associated with complicated buprenorphine inductionsJ Subst Abuse Treat201039515720682186
   PubMed Web of Science ®Google Scholar
• DoranCMBuprenorphine, buprenorphine/naloxone and methadone maintenance: a cost-effectiveness analysisExpert Rev Pharmacoecon Outcomes Res2005558359119807585
   PubMedGoogle Scholar
• BonhommeJShimRSGoodenRTyusDRustGOpioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment optionsJ Natl Med Assoc201210434235023092049
   PubMed Web of Science ®Google Scholar
• LeeJDGrossmanEDiRoccoDGourevitchMNHome buprenorphine/naloxone induction in primary careJ Gen Intern Med20092422623219089508
   PubMed Web of Science ®Google Scholar
• WalleyAYAlperenJKChengDMOffice-based management of opioid dependence with buprenorphine: clinical practices and barriersJ Gen Intern Med20082391393139818592319
   PubMed Web of Science ®Google Scholar
• MintzerILEisenbergMTerraMMacVaneCHimmelsteinDUWoolhandlerSTreating opioid addiction with buprenorphine-naloxone in community-based primary care settingsAnn Fam Med20075214615017389539
   PubMed Web of Science ®Google Scholar
• GundersonEWWangXQFiellinDABryanBLevinFRUnobserved versus observed office buprenorphine/naloxone induction: a pilot randomized clinical trialAddict Behav20103553754020106601
   PubMed Web of Science ®Google Scholar
• FarrellMWodakAGowingLMaintenance drugs to treat opioid dependenceBMJ2012344e282322589497
   PubMed Web of Science ®Google Scholar
• KrausMLAlfordDPKotzMMStatement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addictionJ Addict Med2011525426322042215
   PubMed Web of Science ®Google Scholar
• EhretGBDesmeulesJABroersBMethadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacologyExpert Opin Drug Saf2007628930317480178
   PubMed Web of Science ®Google Scholar
• FishmanMJWuLTWoodyGEBuprenorphine for prescription opioid addiction in a patient with depression and alcohol dependenceAm J Psychiatry201116867567921724673
   PubMed Web of Science ®Google Scholar
• MartellBAArnstenJHKrantzMJGourevitchMNImpact of methadone treatment on cardiac repolarization and conduction in opioid usersAm J Cardiol20059591591815781034
   PubMed Web of Science ®Google Scholar
• WhitleySDKuninsHVArnstenJHGourevitchMNColocating buprenorphine with methadone maintenance and outpatient chemical dependency servicesJ Subst Abuse Treat200733859017588493
   PubMed Web of Science ®Google Scholar
• ManelliPPeindlKSLeeTBhatiaKSWuLTBuprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectivesCurr Drug Abuse Rev20125526322280332
   PubMedGoogle Scholar
• KnudsenHKDucharmeLJRomanPMEarly adoption of buprenorphine in substance abuse treatment centers: data from the private and public sectorsJ Subst Abuse Treat20063036337316716852
   PubMed Web of Science ®Google Scholar
• BaxterLEClinical Guidance on Methadone Induction and StabilizationChevy Chase (MD)American Society of Addiction Medicine2009
   Google Scholar
• JosephHStancliffSLagrodJMethadone maintenance treatment (MMT): a review of historical and clinical issues [review]Mt Sinai J Med20006734736411064485
   PubMed Web of Science ®Google Scholar
• LingWCharuvastraCCollinsJBuprenorphine maintenance treatment of opiate dependence: a multicenter randomized clinical trialAddiction1998934754869684386
   PubMed Web of Science ®Google Scholar
• AhmadiJMethadone versus buprenorphine maintenance for the treatment of heroin-dependent outpatientsJ Subst Abuse Treat20032421722012810142
   PubMed Web of Science ®Google Scholar
• KakkoJGrönbladhLSvanborgKA stepped care strategy using buprenorphine and methadone versus conventional methadone maintenance in heroin dependence: a randomized controlled trialAm J Psychiatry200716479780317475739
   PubMed Web of Science ®Google Scholar
• FareedAVayalapalliSCasarellaJDexlerKTreatment outcome for flexible dosing buprenorphine maintenance treatmentAm J Drug Alcohol Abuse20123815516022175698
   PubMed Web of Science ®Google Scholar
• World Health OrganizationGuidelines for the Psychosocially Assisted Pharmalogical Treatment of Opioid DependenceGenevaWHO2009 Available from: http://www.who.int/substance_abuse/publications/opioid_dependence_guidelines.pdfAccessed January 30, 2014
   Google Scholar
• WangRYoungLDouble-blind controlled detoxification from buprenorphineNIDA Res Monogr1996162114
   Google Scholar
• PychaCResnickRGalanterMBuprenorphine: rapid and slow dose-reduction for heroin detoxificationNIDA Res Monogr1994141453
   Google Scholar
• AmassLBickelWHigginsSHughesJA preliminary investigation of outcome following gradual or rapid buprenorphine detoxificationJ Addict Dis19941333457734458
   PubMed Web of Science ®Google Scholar
• LingWHillhouseMDornierCBuprenorphine tapering schedule and illicit opioid useAddiction200910425626519149822
   PubMed Web of Science ®Google Scholar
• KatzECSchwartzRPKingSBrief vs extended buprenorphine detoxification in a community treatment program: engagement and short term outcomesAm J Drug Alcohol Abuse200935636719199166
   PubMed Web of Science ®Google Scholar
• KleberHDWeissRDAntonRFPractice guidelines for the treatment of patients with substance use disorderssecond editionArlington (VA)American Psychiatric Association (APA)82006 http://psychiatryonline.org/pdfaccess.ashx?ResourceID=243188&PDFSource=6Accessed November 18, 2013
   Google Scholar
• DutraLStathopoulouGBasdenSLLeyroTMPowersMBOttoMWA meta-analytic review of psychosocial interventions for substance use disordersAm J Psychiatry200816517918718198270
   PubMed Web of Science ®Google Scholar
• PendergastMPodusDFinneyJGreenwellLRollJContingency management for treatment of substance use disorders: a meta-analysisAddiction201010115461560
   Web of Science ®Google Scholar
• CampbellBKFullerBELeeESFacilitating outpatient treatment entry following detoxificationPsychology of Addictive Behaviours2009232260270
   PubMed Web of Science ®Google Scholar
• FiellinDAPantalonMChawarskiMCounselling plus buprenorphine-naloxone maintenance therapy for opioid dependenceN Engl J Med200635536537416870915
   PubMed Web of Science ®Google Scholar
• WeissRDPotterJSProvostSEA multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): Rationale, design, and methodologyContemp Clin Trials20103118919920116457
   PubMed Web of Science ®Google Scholar
• WedamEFBigelowGJohnsonRNuzzoPHaigneyMQT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trialArch Intern Med20071672469247518071169
   PubMed Web of Science ®Google Scholar
• AnchersonKClausenTGossopMHansteenVWaalHPrevalence and clinical relevance of corrected QT interval prolongation during methadone and buprenorphine treatment: a mortality assessment studyAddiction200910499399919392907
   PubMed Web of Science ®Google Scholar
• LangeWRFudalaPDaxEJohnsonRSafety and side-effects of buprenorphine in the clinical management of heroin addictionDrug Alcohol Depend19902619282209411
   PubMed Web of Science ®Google Scholar
• FudalaPJBridgeTPHerbertSOffice-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxoneN Engl J Med200334994995812954743
   PubMed Web of Science ®Google Scholar
• OrmanJSKeatingGMBuprenorphine/naloxone: a review of its use in the treatment of opioid dependenceDrugs20096957760719368419
   PubMed Web of Science ®Google Scholar
• MattickRPBreenCKimberJDavoliMMethadone maintenance therapy versus no opioid replacement for opioid dependenceCochrane Database Syst Rev20093CD00220919588333
   PubMed Web of Science ®Google Scholar
• FischerGOrtnerRRohrmeisterKMethadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison studyAddiction200610127528116445556
   PubMed Web of Science ®Google Scholar
• LavieEFatseasMDenisCAuriacombeMBenzodiazepine use among opiate-dependent subjects in buprenorphine maintenance treatment: correlates of use, abuse and dependenceDrug Alcohol Depend20099933834418824311
   PubMed Web of Science ®Google Scholar
• House of Delegates of the Federation of State Medical BoardsModel Policy on DATA 2000 and Treatment of Opioid Addiction in Medical OfficesUnited StatesFederation of State Medical Boards42013 Available from: http://www.fsmb.org/pdf/2013_model_policy_treatment_opioid_addiction.pdfAccessed January 2014
   Google Scholar
• KaltenbachKBerghellaVFinneganLOpioid dependence during pregnancy: effects and managementObstet Gynecol Clin North Am1998251391519547764
   PubMed Web of Science ®Google Scholar
• Fajemirokun-OdudeyiOSinhaCTuttySPregnancy outcome in women who use opiatesEur J Obstet Gynecol Reprod Biol200612617017516202501
   PubMed Web of Science ®Google Scholar
• JonesHEKaltenbachKHeilSHNeonatal abstinence syndrome after methadone or buprenorphine exposureN Engl J Med20103632320233121142534
   PubMed Web of Science ®Google Scholar
• JonesHEFischerGHeilSHMaternal Opioid Treatment: Human Experimental Research (MOTHER) – approach, issues, and lessons learnedAddiction2012107Suppl 1283523106924
   PubMed Web of Science ®Google Scholar
• Academy of Breastfeeding Medicine Protocol CommitteeJanssonLMABM Clinical Protocol #21: Guidelines for Breastfeeding and the Drug-Dependent WomanBreastfeed Med2009422522819835481
   PubMed Web of Science ®Google Scholar
• HayesBDKlein-SchwartzWDoyonSToxicity of buprenorphine overdoses in childrenPediatrics2008121e782e78618381506
   PubMed Web of Science ®Google Scholar
• BellJMutchCTreatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file reviewDrug Alcohol Rev20062516717116627307
   PubMed Web of Science ®Google Scholar
• WoodyGPooleSASubramaniamGExtended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trialJAMA20083002003201118984887
   PubMed Web of Science ®Google Scholar
• FiellinDATreatment of adolescent opioid dependence: no quick fixJAMA20083002057205918984896
   PubMed Web of Science ®Google Scholar
• LevySVaughanBLAnguloMKnightJRBuprenorphine replacement therapy for adolescents with opioid dependence: early experience from a children’s hospital-based outpatient treatment programJ Adolesc Health20074047748817448411
   PubMed Web of Science ®Google Scholar
• AlticeFLBruceRDLucasGMHIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite studyJ Acquir Immune Defic Syndr201156Suppl 1S22S3221317590
   PubMed Web of Science ®Google Scholar
• McCance-KatzEFSullivanLSNallaniSDrug interactions of clinical importance between the opioids, methadone and buprenorphine, and frequently prescribed medications: a reviewAm J Addict20091941620132117
   PubMed Web of Science ®Google Scholar